Prepare for the Certification in Clinical Sleep Health exam. Use flashcards and multiple-choice questions with hints and explanations. Ace your exam!

Multiple Choice

Which medication is listed as a subcutaneous agent used to treat myocardial infarction (MI)?

Subcutaneous anticoagulant therapy helps limit clot growth and prevent recurrent ischemia in acute MI. Enoxaparin (Lovenox) is given by subcutaneous injection and is a standard subcutaneous anticoagulant used in acute coronary syndromes and MI. The other options are not given subcutaneously: clopidogrel (Plavix) is oral, warfarin (Coumadin) is oral, and atenolol (a beta-blocker) is also oral. So enoxaparin is the subcutaneous agent appropriate for treating MI in this list.

Subcutaneous anticoagulant therapy helps limit clot growth and prevent recurrent ischemia in acute MI. Enoxaparin (Lovenox) is given by subcutaneous injection and is a standard subcutaneous anticoagulant used in acute coronary syndromes and MI. The other options are not given subcutaneously: clopidogrel (Plavix) is oral, warfarin (Coumadin) is oral, and atenolol (a beta-blocker) is also oral. So enoxaparin is the subcutaneous agent appropriate for treating MI in this list.